130 related articles for article (PubMed ID: 38682268)
1. Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication.
Chen J; Zhang Y; Min H; Zhi J; Ma S; Dong H; Yan J; Chi X; Zhang X; Yang Y
Helicobacter; 2024; 29(2):e13077. PubMed ID: 38682268
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
[TBL] [Abstract][Full Text] [Related]
3. High-dose dual therapy versus bismuth-containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta-analysis.
Wang H; Kong QZ; Li YY; Yang XY; Zuo XL
J Dig Dis; 2024 Mar; 25(3):163-175. PubMed ID: 38577962
[TBL] [Abstract][Full Text] [Related]
4. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
Liou JM; Jiang XT; Chen CC; Luo JC; Bair MJ; Chen PY; Chou CK; Fang YJ; Chen MJ; Chen CC; Lee JY; Yang TH; Yu CC; Kuo CC; Chiu MC; Chen CY; Shun CT; Hu WH; Tsai MH; Hsu YC; Tseng CH; Chang CY; Lin JT; El-Omar EM; Wu MS;
Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):228-241. PubMed ID: 36549320
[TBL] [Abstract][Full Text] [Related]
5. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
[TBL] [Abstract][Full Text] [Related]
6. High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of
Zhang C; Zhang J; Cheng YJ
Saudi J Gastroenterol; 2023; 29(2):88-94. PubMed ID: 36960527
[TBL] [Abstract][Full Text] [Related]
7. High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis.
Yang X; Wang JX; Han SX; Gao CP
Medicine (Baltimore); 2019 Feb; 98(7):e14396. PubMed ID: 30762742
[TBL] [Abstract][Full Text] [Related]
8. Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children.
Zhou Y; Ye Z; Lu J; Miao S; Lu X; Sun H; Wu J; Wang Y; Huang Y
Helicobacter; 2020 Oct; 25(5):e12721. PubMed ID: 32656891
[TBL] [Abstract][Full Text] [Related]
9. Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children.
Zhou Y; Ye Z; Wang Y; Huang Z; Zheng C; Shi J; Tang W; Zhang P; Wang S; Huang Y
Helicobacter; 2021 Aug; 26(4):e12809. PubMed ID: 33899288
[TBL] [Abstract][Full Text] [Related]
10. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS;
Lancet Infect Dis; 2019 Oct; 19(10):1109-1120. PubMed ID: 31559966
[TBL] [Abstract][Full Text] [Related]
11. Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg).
Nyssen OP; Perez-Aisa A; Rodrigo L; Castro M; Mata Romero P; Ortuño J; Barrio J; Huguet JM; Modollel I; Alcaide N; Lucendo A; Calvet X; Perona M; Gomez B; Gomez Rodriguez BJ; Varela P; Jimenez-Moreno M; Dominguez-Cajal M; Pozzati L; Burgos D; Bujanda L; Hinojosa J; Molina-Infante J; Di Maira T; Ferrer L; Fernández-Salazar L; Figuerola A; Tito L; de la Coba C; Gomez-Camarero J; Fernandez N; Caldas M; Garre A; Resina E; Puig I; O'Morain C; Megraud F; Gisbert JP
Helicobacter; 2020 Oct; 25(5):e12722. PubMed ID: 32656898
[TBL] [Abstract][Full Text] [Related]
12. Probiotics modulate gastrointestinal microbiota after
He C; Xie Y; Zhu Y; Zhuang K; Huo L; Yu Y; Guo Q; Shu X; Xiong Z; Zhang Z; Lyu B; Lu N
Front Immunol; 2022; 13():1033063. PubMed ID: 36426355
[TBL] [Abstract][Full Text] [Related]
13. High-dose amoxicillin-proton pump inhibitor dual therapy as first-line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial.
Yun JW; Wang C; Yu Y; Xu HM; Gou LZ; Li XL; Yi GR; Lin YM; Han TY; Zhang DK
Br J Clin Pharmacol; 2023 Jan; 89(1):232-241. PubMed ID: 35947524
[TBL] [Abstract][Full Text] [Related]
14. The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
Zagari RM; Romiti A; Ierardi E; Gravina AG; Panarese A; Grande G; Savarino E; Maconi G; Stasi E; Eusebi LH; Farinati F; Conigliaro R; Bazzoli F; Romano M
Helicobacter; 2018 Aug; 23(4):e12502. PubMed ID: 29924430
[TBL] [Abstract][Full Text] [Related]
15. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.
Poonyam P; Chotivitayatarakorn P; Vilaichone RK
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the traditional triple and a new bismuth-containing quadruple therapy in the first-line eradication of
Varga M; Drácz L; Kolbenheyer E; Varga F; Patai ÁV; Solymosi N; Patai Á
Orv Hetil; 2019 Aug; 160(34):1340-1345. PubMed ID: 31423829
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial.
Bi H; Chen X; Chen Y; Zhao X; Wang S; Wang J; Lyu T; Han S; Lin T; Li M; Yuan D; Liu J; Shi Y
Chin Med J (Engl); 2022 Jul; 135(14):1707-1715. PubMed ID: 36193978
[TBL] [Abstract][Full Text] [Related]
18. Metagenomic Changes of Gut Microbiota following Treatment of
Dore MP; Sau R; Niolu C; Abbondio M; Tanca A; Bibbò S; Loria M; Pes GM; Uzzau S
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889746
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy and Safety of Regimens for Helicobacter pylori Eradication Treatment in China: A Systemic Review and Network Meta-Analysis.
Li J; Shi H; Zhou F; Xie L; Lin R
J Clin Gastroenterol; 2024 Jan; 58(1):12-23. PubMed ID: 38084866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
